FOR IMMEDIATE WORLDWIDE RELEASE

For Further Information, Contact:

Jim Green
President & CEO
(978) 326-4000

Paul M. Roberts
Director of Communications
(978) 326-4213
proberts@analogic.com

Analogic Corporation Receives $17.5 Million Order for Its
Explosive Assessment Computed Tomography Systems and Upgrade Components

PEABODY, MASS. (August 15, 2007) — Analogic Corporation (NASDAQ: ALOG) announced today that it has received an order from L-3 Communications (NYSE: LLL) for EXplosive Assessment Computed Tomography (EXACT®) systems and associated upgrade equipment valued at $17.5 million. The EXACT is the heart of the certified eXaminer 3DX® Explosives Detection System (EDS), developed jointly by L-3 and Analogic and distributed exclusively by L-3 for screening checked baggage at airports. The system features advanced multi-slice CT imaging technology and provides full 3-D images of all the contents of a bag, enabling automatic detection of explosives. The hardware upgrades will enable airports to upgrade eXaminer systems already in the field.

Jim Green, President and CEO of Analogic, said, “We’re pleased to receive another order for EXACT systems from L-3. Working closely with L-3, we have become the industry leaders in providing the most capable and reliable checked baggage solution for airports. Over 750 eXaminers have been installed around the world to date. Also, the L-3/Analogic team is working closely with the Transportation Security Administration (TSA) to achieve substantial long-term savings for airports and the TSA through the expanded use of enhanced, in-line EDS installations.” Green added that Analogic expects to start shipping the first systems from this order in early calendar 2008.

Analogic Corporation is a leading designer and manufacturer of advanced health and security systems and subsystems. The Company is recognized worldwide for advancing the state of the art in Automated Explosives Detection, Computed Tomography (CT), Digital Radiography (DR), Ultrasound, Magnetic Resonance Imaging (MRI), Patient Monitoring, and Advanced Signal Processing. For more information, please visit www.analogic.com.

Forward-Looking Statements

Any statements in this press release about future expectations, plans, and prospects for Analogic Corporation (the “Company”), including statements about orders for the Company’s products, statements about shipments and installation of the Company’s products, and other statements containing the words “believes,” “anticipates,” “plans,” “expects,” and similar expressions, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including risks relating to technology development and commercialization, risks in product development, limited demand for the Company’s products, risks associated with competition, uncertainties associated with regulatory agency approvals, competitive pricing pressures, downturns in the economy, the risk of potential intellectual property litigation, and other factors discussed in our most recent quarterly report filed with the Securities and Exchange Commission. In addition, the forward-looking statements included in this press release represent the Company’s views as of August 15, 2007. The Company anticipates that subsequent events and developments will cause the Company’s views to change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company’s views as of any date subsequent to August 15, 2007.

TERMS OF USE
© 2003 Analogic Corporation. All rights reserved

Back to Home Page